Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tan

Showing results (531-540 of 640) with videos related to

Pageof 64
Sort By:
Breast Cancer Research and Treatment|July 15, 2021
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancerRebecca Dent, Mafalda Oliveira, Steven J Isakoff, et al.
Virology|October 4, 2019
Attenuation of a virulent swine acute diarrhea syndrome coronavirus strain via cell culture passageY Sun, J Cheng, Y Luo, et al.
Oncology Nursing Forum|August 24, 2025
Physical Function and Mobility in Older Adults Receiving Treatment for Acute Myeloid Leukemia: A Longitudinal Qualitative StudyAhrang Jung, Victoria Crowder, Ya-Ning Chan, et al.
American Journal of Clinical Oncology|June 14, 2022
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor MalignanciesPaula M Fracasso, Sherry A Goodner, Jonathan D Wildi, et al.
The Oncologist|December 15, 2010
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumorsAntoinette R Tan, Afshin Dowlati, Suzanne F Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancerHarold J Burstein, Yan Sun, Luc Y Dirix, et al.
The Oncologist|December 16, 2018
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)Herbert I Hurwitz, Benjamin R Tan, James A Reeves, et al.
Malaria Journal|February 20, 2016
A longitudinal study of the durability of long-lasting insecticidal nets in ZambiaKathrine R Tan, Jane Coleman, Barbara Smith, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 14, 2025
"<i>How am I Going to Live? How am I Going to Pay Rent?"</i>: A Mixed Methods Investigation of Employment, Stigma, and Financial Hardship Among LGBTQ+ Cancer CaregiversAustin R Waters, Erin E Kent, Camille R Murray, et al.
Emerging Infectious Diseases|February 5, 2026
Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, CambodiaWilliam W Davis, Kathrine R Tan, Borann Sar, et al.
Pageof 64

Showing results (531-540 of 640) with videos related to

Sort By:
Pageof 64
Breast Cancer Research and Treatment|July 15, 2021
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancerRebecca Dent, Mafalda Oliveira, Steven J Isakoff, et al.
Virology|October 4, 2019
Attenuation of a virulent swine acute diarrhea syndrome coronavirus strain via cell culture passageY Sun, J Cheng, Y Luo, et al.
Oncology Nursing Forum|August 24, 2025
Physical Function and Mobility in Older Adults Receiving Treatment for Acute Myeloid Leukemia: A Longitudinal Qualitative StudyAhrang Jung, Victoria Crowder, Ya-Ning Chan, et al.
American Journal of Clinical Oncology|June 14, 2022
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor MalignanciesPaula M Fracasso, Sherry A Goodner, Jonathan D Wildi, et al.
The Oncologist|December 15, 2010
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumorsAntoinette R Tan, Afshin Dowlati, Suzanne F Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2010
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancerHarold J Burstein, Yan Sun, Luc Y Dirix, et al.
The Oncologist|December 16, 2018
Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM)Herbert I Hurwitz, Benjamin R Tan, James A Reeves, et al.
Malaria Journal|February 20, 2016
A longitudinal study of the durability of long-lasting insecticidal nets in ZambiaKathrine R Tan, Jane Coleman, Barbara Smith, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 14, 2025
"<i>How am I Going to Live? How am I Going to Pay Rent?"</i>: A Mixed Methods Investigation of Employment, Stigma, and Financial Hardship Among LGBTQ+ Cancer CaregiversAustin R Waters, Erin E Kent, Camille R Murray, et al.
Emerging Infectious Diseases|February 5, 2026
Detecting Influenza A(H5N1) Viruses through Severe Acute Respiratory Infection Surveillance, CambodiaWilliam W Davis, Kathrine R Tan, Borann Sar, et al.
Pageof 64